FRONTIER CAPITAL MANAGEMENT CO LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 107 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,435,000
+20.4%
629,154
-0.5%
0.04%
+21.2%
Q2 2022$2,853,000
-69.7%
632,506
-50.6%
0.03%
-61.2%
Q1 2022$9,428,000
-13.0%
1,279,295
-24.1%
0.08%
-1.2%
Q4 2021$10,837,000
+68.9%
1,685,405
+52.9%
0.09%
+72.0%
Q3 2021$6,416,000
-58.2%
1,102,427
-26.0%
0.05%
-55.8%
Q2 2021$15,366,000
+19.6%
1,488,939
+21.9%
0.11%
+16.5%
Q1 2021$12,852,000
-73.5%
1,221,627
-60.9%
0.10%
-72.9%
Q4 2020$48,415,000
-10.5%
3,127,571
-15.6%
0.36%
-24.2%
Q3 2020$54,075,000
+2.3%
3,703,786
+32.7%
0.47%
+0.9%
Q2 2020$52,852,000
+49.6%
2,790,501
+51.7%
0.47%
+17.9%
Q1 2020$35,336,000
+80.9%
1,839,440
+80.5%
0.40%
+175.7%
Q4 2019$19,537,000
+14.4%
1,019,138
-42.6%
0.14%
+7.5%
Q3 2019$17,084,000
+317.7%
1,775,865
+160.1%
0.13%
+332.3%
Q2 2019$4,090,000
+2.5%
682,853
-0.1%
0.03%
+10.7%
Q1 2019$3,991,000
+156.8%
683,363
+311.9%
0.03%
+115.4%
Q4 2018$1,554,000
-55.4%
165,899
-18.9%
0.01%
-40.9%
Q3 2018$3,484,000
-33.2%
204,556
-33.4%
0.02%
-40.5%
Q2 2018$5,217,000307,0350.04%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,200,396$30,084,0001.72%
TFS CAPITAL LLC 105,040$987,0000.26%
Tekla Capital Management LLC 500,324$4,703,0000.20%
Piermont Capital Management Inc. 51,080$480,0000.11%
ESSEX INVESTMENT MANAGEMENT CO LLC 55,793$524,0000.09%
Candriam S.C.A. 390,000$3,666,0000.08%
Virtus ETF Advisers LLC 27,446$258,0000.08%
SECOR Capital Advisors, LP 66,484$625,0000.08%
Trexquant Investment LP 29,007$273,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 32,196$303,0000.04%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders